HCA Healthcare price target lowered to $392 from $396 at Barclays
Barclays lowered the firm’s price target on HCA Healthcare (HCA) to $392 from $396 and keeps an Overweight rating on the shares. While ...
Business Insider11h
Tenet Healthcare price target raised to $190 from $171 at Barclays
Barclays analyst Andrew Mok raised the firm’s price target on Tenet Healthcare (THC) to $190 from $171 and keeps an Overweight rating on the shares. While 2024 was a “particularly great” year for ...